18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,819 followers.

(18)F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment https://t.co/9AqmfWOxX5

23 Jun 2021

Reply Repost Favourite

New research: 18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment: Background The aim of this study was to evaluate 18F-AlF-NOTA-PRGD2 positron… https://t.co/VkLIX

04 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.